Marker Therapeutics, Inc. (MRKR)

2.23 +0.11 (+5.19%) USD  |  NASDAQ  |  Jan 21, 14:08
More

Marker Therapeutics Preferred Stock (Quarterly)

Preferred Stock (Quarterly) Chart

View Preferred Stock (Quarterly) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Stock (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Stock (Quarterly) Range, Past 5 Years

View Preferred Stock (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Stock (Quarterly) Benchmarks

View Preferred Stock (Quarterly) Benchmarks
Start Trial
Viridian Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade